Abstract

We studied the effects of nicardipine (initial infusion rate 0.5 μ·kg−1·min−1) on blood flow velocity in the internal carotid artery, local cerebral blood flow (LCBF), and carbon dioxide reactivity in 20 patients undergoing craniotomy for cerebral aneurysm clipping under isoflurane anesthesia. The blood flow velocity in the internal carotid artery was measured at T0 and T3 by a 20-MHz pulsed ultrasound Doppler flowmeter. LCBF was measured by the thermal gradient blood flow meter. Group A consisted of 10 patients with a good neurologic status (Hunt and Kosnik Grade I); Group B consisted of 10 patients with a poor status (Grades II-IV). Nicardipine was infused until the mean arterial blood pressure decreased to about 75% of the initial value and was maintained at this level until the completion of aneurysm clipping. The measurements of hemodynamics and LCBF were performed after the exposure of the internal carotid artery (T0), and 10 and 30 min after the start of nicardipine (T1 and T2, respectively), before aneurysm clipping (T3), and 30 min after its discontinuation (T4). Carbon dioxide reactivity [% ÂLCBF/ÂPaCO2 (% / mm Hg)] was evaluated at T0, T3, and T4. Mean arterial blood pressure decreased after nicardipine infusion in both groups. LCBF did not change during nicardipine infusion in either group. Blood flow velocity increased significantly in Group A after nicardipine infusion from 45.1 ± 6.9 to 51.5 ± 6.4 cm/s (P < 0.05), but in Group B flow velocity did not change. Carbon dioxide reactivity did not change after nicardipine infusion but correlated with LCBF before (r2 = 0.495, P < 0.05), during (r2 = 0.706, P < 0.01), and after hypotension (r2 = 0.555, P < 0.05). These results suggest that nicardipine may be a useful drug to treat intraoperative hypertension during cerebral aneurysm surgery. (Anesth Analg 1993;76:1227-33)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.